droperidol has been researched along with palonosetron in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Gong, L; Hu, X; Tan, F | 1 |
1 review(s) available for droperidol and palonosetron
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for droperidol and palonosetron
| Article | Year |
|---|---|
Higher dose of palonosetron versus lower dose of palonosetron plus droperidol to prevent postoperative nausea and vomiting after eye enucleation and orbital hydroxyapatite implant surgery: a randomized, double-blind trial.
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Antiemetics; Dose-Response Relationship, Drug; Double-Blind Method; Droperidol; Durapatite; Eye Enucleation; Female; Humans; Incidence; Isoquinolines; Male; Middle Aged; Orbital Implants; Palonosetron; Postoperative Nausea and Vomiting; Prospective Studies; Prosthesis Implantation; Quinuclidines; Young Adult | 2017 |